Traditional Chinese medicine for treating atrophic gastritis

Abstract

The invention relates to a traditional Chinese medicine for treating atrophic gastritis. The medicine is characterized by being prepared from the following raw materials: rhizoma zingiberis, codonopsis pilosula, poria cocos, rhizoma corydalis, panax notoginseng, cuttlebone, radix pseudostellariae, endothelium corneum gigeriae galli, coix seeds, dandelion, selfheal, garden burnet, rhizoma cimicifugae, oysters, turtle shells, ginseng, watermelon seeds, medicated leaven, eclipta, Indian iphigenia bulbs and pumpkin seeds. The medicine is used for treating the atrophic gastritis caused by helicobacter pylori infection, a poor dietary habit, genetic factors, superficial gastritis development and the like, accompanied with symptoms such as a stomach swelling pain, heart burn, vomiting, haematemesis, dyspepsia, fecal abnormality and anemia, protects a stomach mucous membrane, improves intestinal epidermic metaplasia and therefore achieves the purposes of alleviation and curing through warming the middle-jiao, dispelling cold, strengthening the spleen and the stomach, promoting blood circulation, dissipating blood stasis, tonifying qi, promoting production of body fluid, nourishing yin and clearing away heat in company with astringency, hemostasis, swelling diminishing and stasis removal. The medicine is a pure traditional Chinese medicine preparation, is free from chemical ingredients and any hormone, has no side effect, is convenient to take, easy to absorb and low in price and takes effect quickly.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines and relates to a traditional Chinese medicine for treating atrophic gastritis. Background technique [0002] Atrophic gastritis is a common disease in gastropathy. Under gastroscopy, the gastric mucosa becomes thinner, whiter in color, submucosal blood vessels are seen through, and granular proliferation on the mucosal surface is uneven. There are many pathogenic factors, such as Helicobacter pylori infection, poor diet, genetic factors, development of superficial gastritis, etc. Patients usually have symptoms such as stomach pain, heartburn, vomiting, hematemesis, indigestion, abnormal stool, and anemia. Atrophic gastritis is often accompanied by intestinal metaplasia. According to statistics, 65.5% of patients with atrophic gastritis are accompanied by intestinal metaplasia. Incomplete metaplasia of the large intestine in intestinal metaplasia is closely related to gastric cancer and...

AI Technical Summary

Problems solved by technology

The above drugs can relieve or inhibit the further deterioration of the disease in a short period of time. Since atrophic gastritis is usually a chronic disease, long-term drug treatment is required, but these drugs generally have drug resistance and adverse reactions, so they cannot be taken for a long time. In addition to adverse reactions such as nausea, flushing, headache, dizziness, gastrointestinal cramps and hypotension, peptide gastrin also has allergic reactions. At the same time, it cannot be used by patients with peptic ulcer and cannot be widely used

Images